BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study

BACKGROUND: The approval of epoetin biosimilars in the European Union requires extensive scientific evaluation and stringent regulatory procedures, including post-marketing studies. The ORHEO (place of biOsimilaRs in the therapeutic management of anaemia secondary to chemotherapy in HaEmatology and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Michallet, Mauricette, Luporsi, Elisabeth, Soubeyran, Pierre, Amar, Nadia Ali, Boulanger, Vincent, Carreiro, Miguel, Dourthe, Louis-Marie, Labourey, Jean-Luc, Lepille, Daniel, Maloisel, Frédéric, Mouysset, Jean-Loup, Nahon, Sophie, Narciso, Bérengère, Nouyrigat, Pierre, Radji, Raouf, Sakek, Nacéra, Albrand, Hélène
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4227033/
https://ncbi.nlm.nih.gov/pubmed/25011615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-503
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars